Bisulepin

Bisulepin is a tricyclic antidepressant (TCA) that was developed in the 1960s but was never marketed. It is structurally related to other tricyclic antidepressants such as amitriptyline and imipramine.

Pharmacology[edit | edit source]

Bisulepin, like other tricyclic antidepressants, works by inhibiting the reuptake of certain neurotransmitters in the brain, specifically serotonin and norepinephrine. This increases the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.

Chemistry[edit | edit source]

Bisulepin is a tricyclic compound, meaning it has three rings in its chemical structure. It is structurally similar to other tricyclic antidepressants, which also have three-ring structures.

History[edit | edit source]

Bisulepin was developed in the 1960s as a potential treatment for depression. However, it was never marketed, possibly due to the development of newer antidepressants with fewer side effects.

References[edit | edit source]

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.